The global tissue diagnostics market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period (2022-2028). Tissues are used to diagnose and classify diseases. They are used to identify if a patient has cancer as well as what kind of cancer and the characteristics of cancer. Additionally, tissue diagnostics capture the disease insights and the parameters that factor into the patient outcomes. The major factor driving the growth of the global tissue diagnostics market during the forecast period is the increasing healthcare expenditure across the globe.
Browse the full report description of "Global Tissue Diagnostics Market Size, Share & Trends Analysis Report, By Technology (Immunohistochemistry, In-Situ Hybridization, H&E Stain, Special Staining, Digital Pathology and Others), By Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Carcinoma and Others), By Product (Instrument (Slide Staining Systems, Scanners, Tissue Processing Systems and Others) and Consumables (Antibody, Kits, Reagents, Probes and Others)), By End-User (Hospitals & Clinics, Laboratories & Research Institutes, and Others), Forecast (2022-2028)" at https://www.omrglobal.com/industry-reports/tissue-diagnostics-market
According to the Centers for Medicare & Medicaid Services (CMS), in 2020, the US health care spending grew 9.7%, reaching $4.1 trillion and a total of $12,530 per person. Additionally, healthcare spending accounted for 19.7% of the nation's Gross Domestic Product. Furthermore, according to World Health Organization (WHO), the global healthcare expenditure was 9.8% of the world’s GDP in 2018. Moreover, the growth of the market is also attributed to the growing geriatric population globally. According to the Department of Economic and Social Affairs, there were 703 million people aged 65 years or over globally in 2019 which is anticipated to double to 1.5 billion in 2050. Hence, these factors are driving the growth of the global tissue diagnostics market during the forecast period.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape-Abbott Laboratories, F. Hoffmann-La Roche AG, Bio-Genex Laboratories, Bio SB Inc., and Agilent Technologies.
Key questions addressed by the report
oDeviation from the pre-COVID-19 forecast
oMost affected region and segment
Global Tissue Diagnostics Market Report by Segment
By Technology
By Diagnosis
By Product
Consumables
By End-User
Global Tissue Diagnostics Market Report by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/tissue-diagnostics-market